Front Row Advisors LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,004 filers reported holding BAXTER INTL INC in Q3 2022. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Front Row Advisors LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2024$23,089
-21.6%
6840.0%0.01%
-27.3%
Q1 2024$29,446
+237.0%
684
+205.4%
0.01%
+175.0%
Q4 2023$8,737
-66.4%
224
-67.3%
0.00%
-66.7%
Q3 2023$26,025
+83851.6%
6840.0%0.01%
-14.3%
Q2 2023$31
+6.9%
684
-4.2%
0.01%0.0%
Q1 2023$29
+16.0%
714
+45.7%
0.01%
+7.7%
Q4 2022$25
-99.9%
490
-31.3%
0.01%
-35.0%
Q3 2022$39,000
-15.2%
713
+0.1%
0.02%
-13.0%
Q2 2022$46,000
-16.4%
712
+0.1%
0.02%
+4.5%
Q1 2022$55,000
-9.8%
7110.0%0.02%
-4.3%
Q4 2021$61,000
+7.0%
711
+0.1%
0.02%
-4.2%
Q3 2021$57,000
+7.5%
7100.0%0.02%
+9.1%
Q2 2021$53,000
-11.7%
710
+0.1%
0.02%
-24.1%
Q1 2021$60,000
+5.3%
709
+0.1%
0.03%0.0%
Q4 2020$57,000
+3.6%
708
-1.9%
0.03%0.0%
Q3 2020$55,000
-11.3%
722
+0.1%
0.03%
-23.7%
Q2 2020$62,000
-3.1%
7210.0%0.04%
-11.6%
Q1 2020$64,000
+12.3%
721
+6.8%
0.04%
+16.2%
Q4 2019$57,000
-3.4%
6750.0%0.04%
-11.9%
Q3 2019$59,0000.0%675
-6.0%
0.04%
-2.3%
Q2 2019$59,000
+1.7%
7180.0%0.04%
-4.4%
Q1 2019$58,000
+75.8%
718
+42.5%
0.04%
+55.2%
Q4 2018$33,000
-2.9%
5040.0%0.03%
+20.8%
Q3 2018$34,000
-10.5%
5040.0%0.02%0.0%
Q2 2018$38,000
+15.2%
5040.0%0.02%
+4.3%
Q1 2018$33,0000.0%5040.0%0.02%
-11.5%
Q4 2017$33,0005040.03%
Other shareholders
BAXTER INTL INC shareholders Q3 2022
NameSharesValueWeighting ↓
Soditic Asset Management LLP 147,620$7,951,0009.91%
NUANCE INVESTMENTS, LLC 5,429,702$292,444,0006.51%
Endurant Capital Management LP 245,093$13,201,0004.30%
Veritas Asset Management LLP 8,589,401$462,625,0003.83%
GENERATION INVESTMENT MANAGEMENT LLP 11,876,040$639,644,0003.80%
Sivik Global Healthcare LLC 120,000$6,463,0003.59%
KINGDON CAPITAL MANAGEMENT, L.L.C. 480,500$25,880,0003.31%
Integral Health Asset Management, LLC 300,000$16,158,0003.14%
Boothe Investment Group, Inc. 89,078$4,798,0003.11%
Glenview Capital Management 2,257,019$121,563,0003.04%
View complete list of BAXTER INTL INC shareholders